This implementation evaluation examined integration of heat-stable carbetocin (HSC) into routine Active Management of the Third Stage of Labour (AMTSL) across 32 public-sector delivery facilities in Dewas district, Madhya Pradesh, India. The intervention was delivered through a phased public–private partnership and combined introduction of HSC into labour-room practice with provider capacity building, strengthened documentation, and supportive supervision.
A retrospective observational analysis used routinely collected facility-level records covering August 2022 to December 2024. The evaluation included all documented institutional deliveries in the participating facilities during the study period. Key outcomes prespecified for analysis were prophylactic uterotonic coverage, timing of uterotonic administration, incidence of postpartum haemorrhage (PPH), and PPH management practices. The study received approval from the Institutional Review Board of the International Institute of Health Management Research (IIHMR), New Delhi (IRB No. IIHMR D/SRB/2/2022).
Across 48,487 institutional deliveries recorded during the study, documented prophylactic uterotonic coverage was nearly universal at 99.9%. Administration within one minute of birth—an AMTSL timing target—was achieved in 99.4% of deliveries. These findings indicate high fidelity to the AMTSL elements captured in routine facility records following programmatic implementation of the model.
Among deliveries with documented prophylactic uterotonic use, 41,658 (85.9%) received HSC and 6,812 (14.1%) received oxytocin. Allocation to HSC or oxytocin reflected routine programme implementation rather than random assignment; therefore, comparative outcomes are descriptive. Uptake of HSC varied by facility level (see Differences by facility level), with higher adoption in higher-capacity referral units.
Overall, 275 PPH cases were documented across the district during the study period, corresponding to an incidence of 0.57% among recorded institutional deliveries. Among women receiving HSC prophylaxis, 200 PPH cases were documented (0.48%); among those receiving oxytocin prophylaxis, 75 PPH cases were documented (1.10%). Because uterotonic allocation was not randomized, these incidence figures are descriptive and should not be interpreted as demonstrating causal effectiveness differences.
Uterine atony was the leading documented cause of PPH, accounting for 176 of 275 cases (64.0%). The source reports these cause distributions based on routine clinical documentation.
Management actions documented for the 275 PPH cases included:
These management frequencies derive from routine facility records and reflect the care pathways and resource use documented during the implementation period.
The evaluation compared uptake and timeliness by facility type. HSC uptake was significantly higher in First Referral Units (FRUs) than in non-FRU facilities (89.3% vs 81.4%; p<0.001). Timely administration within one minute among HSC recipients was also higher in FRUs compared with non-FRUs (100% vs 98.7%; p<0.001). These comparisons were reported as part of the routine programme analysis.
The AMTSL strengthening model embedded HSC introduction within existing health-system structures: routine labour-room practice, supervisory systems, reporting channels, and targeted provider training. The reported results show that using existing infrastructure and supervision mechanisms can achieve high prophylactic uterotonic coverage and timely administration across a range of public-sector facilities. The authors suggest that such embedded implementation approaches may provide a pragmatic pathway for strengthening PPH prevention in settings where maintaining the oxytocin cold chain is challenging, though they note that allocation in this real-world rollout was not randomized.
Key limitations of the analysis stem from its retrospective, observational design using routine programme data. Uterotonic allocation reflected programme implementation rather than random assignment, so comparisons of PPH incidence by uterotonic type are descriptive and cannot establish causality. The datasets derive from routine government health facility records and are not publicly available because of confidentiality and government data-access restrictions; aggregated data may be made available on request subject to approvals from relevant authorities.
District-wide implementation of an HSC-based AMTSL strengthening model in Dewas district achieved near-universal documented prophylactic uterotonic coverage and very high rates of administration within one minute of birth across participating public facilities. Uptake of HSC was high (85.9% of documented prophylactic uterotonic use) and greater in higher-level referral units. Documented PPH incidence was 0.57% overall, with uterine atony the leading cause. Management commonly included intravenous fluids, tranexamic acid, and referral or transfusion when needed.
The report provides real-world implementation evidence supporting the feasibility of integrating heat-stable carbetocin into routine government maternity services using existing health-system infrastructure, supervision, and reporting mechanisms. The authors present this as a pragmatic approach for PPH prevention in contexts where oxytocin cold-chain maintenance is unreliable. Because the analysis is observational and based on routine records, further studies using comparative or randomized designs would be required to assess causal effectiveness differences between uterotonics.